Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
Chiang, M.-C., Tsai, T.-Y., & Wang, C.-J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076328 · Cited by 231
Neuroprotective Strategies for Ischemic Stroke—Future Perspectives
Haupt, M., Gerner, S. T., Bähr, M., & Doeppner, T. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054334 · Cited by 202
“Invading neutrophils secrete matrix metalloproteinases, which lead to the breakdown of tight junctions that physiologically ensure the integrity of the BBB [7].”
BackgroundInfluentialAchar, A., Myers, R., & Ghosh, C. (2021) · Biomedicines · doi:10.3390/biomedicines9121834 · Cited by 189
“Ischemic stroke may result from a thrombotic event, in which blood vessel dysfunction obstructs blood flow to the brain, or an embolic event, in which debris or clots from another origin site become dislodged in the vessel, thereby blocking blood flow [67,68].”
BackgroundSalaudeen, M. A., Bello, N., Danraka, R. N., & Ammani, M. L. (2024) · Biomolecules · doi:10.3390/biom14030305 · Cited by 175
“Careful experimental design and clinical trials of stem cell therapies are likely to usher in a new era of treatment for stroke by promoting neurogenesis, rebuilding neural networks, and boosting axonal growth and synaptogenesis [1,99].”
BackgroundRahimi Darehbagh, R., Seyedoshohadaei, S. A., Ramezani, R., & Rezaei, N. (2024) · European Journal of Medical Research · doi:10.1186/s40001-024-01987-1 · Cited by 167
“Combination therapies that target multiple aspects of MS pathology, such as neuroinflammation, oxidative stress, and mitochondrial dysfunction, may enhance the therapeutic potential of stem cell transplantation [120].”
BackgroundRole of Endogenous Lipopolysaccharides in Neurological Disorders
Kalyan, M., Hediyal, T. A., Sonali, S., Vichitra, C., Sunanda, T., Praveenraj, S. S., Ray, B., Gorantla, V. R., Rungratanawanich, W., Mahalakshmi, A. M., et al. (2022) · Cells · doi:10.3390/cells11244038 · Cited by 184
“Several studies have shown that gut microbial dysbiosis can be considered a potential risk factor for stroke development and post-stroke prognosis [10,124,125].”
BackgroundNetala, V. R., Teertam, S. K., Li, H., & Zhang, Z. (2024) · Cells · doi:10.3390/cells13171471 · Cited by 236
Stroke: Molecular mechanisms and therapies: Update on recent developments
Shehjar, F., Maktabi, B., Rahman, Z. A., Bahader, G. A., James, A. W., Naqvi, A., Mahajan, R., & Shah, Z. A. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105458 · Cited by 164
Association between the weight-adjusted waist index and stroke: a cross-sectional study
Ye, J., Hu, Y., Chen, X., Yin, Z., Yuan, X., Huang, L., & Li, K. (2023) · BMC Public Health · doi:10.1186/s12889-023-16621-8 · Cited by 146
“Stroke is a cerebrovascular illness characterized by blood vessel obstruction [1].”
BackgroundThe Nrf2 Pathway in Ischemic Stroke: A Review
Farina, M., Vieira, L. E., Buttari, B., Profumo, E., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26165001 · Cited by 137
“In addition to the aforementioned factors, socioeconomic variation also affects the occurrence and/or outcomes of stroke; for broader information regarding risk factors for ischemic stroke, see reference [14].”
BackgroundThe Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases
Wang, X., Chen, X., Tang, Y., Wu, J., Qin, D., Yu, L., Yu, C., Zhou, X., & Wu, A. (2022) · Pharmaceuticals · doi:10.3390/ph15111329 · Cited by 138
Wang, L., Liu, Y., Zhang, X., Ye, Y., Xiong, X., Zhang, S., Gu, L., Jian, Z., & Wang, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.864426 · Cited by 121
Addressing the challenges of AI-based telemedicine: Best practices and lessons learned
Sharma, S., Rawal, R., & Shah, D. (2023) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_402_23 · Cited by 118
“[35] Telestroke is a medical service that uses telemedicine technology to connect neurologists with patients who are experiencing a stroke in remote or underserved areas.”
BackgroundAlugoju, P., Swamy, V., Anthikapalli, N. V. A., & Tencomnao, T. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2084600 · Cited by 128
Machine learning applications in stroke medicine: advancements, challenges, and future prospectives
Daidone, M., Ferrantelli, S., & Tuttolomondo, A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382228 · Cited by 140
“The value of mild hypothermia for improving stroke outcomes is still being researched (Kuriakose and Xiao, 2020).”
BackgroundIntegrative Approaches in Acute Ischemic Stroke: From Symptom Recognition to Future Innovations
Saceleanu, V. M., Toader, C., Pleș, H., Covache-Busuioc, R.-A., Costin, H. P., Bratu, B.-G., Dumitrascu, D.-I., Bordeianu, A., Corlatescu, A.-D., & Ciurea, A. V. (2023) · Biomedicines · doi:10.3390/biomedicines11102617 · Cited by 160
“Nonetheless, the full translational promise of stroke research remains to be thoroughly explored [347].”
BackgroundIntercellular Adhesion Molecule 1: More than a Leukocyte Adhesion Molecule
Haydinger, C. D., Ashander, L. M., Tan, A. C. R., & Smith, J. R. (2023) · Biology · doi:10.3390/biology12050743 · Cited by 138
Soleimani, M., Ghazisaeedi, M., & Heydari, S. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02534-y · Cited by 155
“In 2019, stroke accounted for approximately 11% of all deaths and was the second leading cause of combined death and disability [2].”
BackgroundInflammasomes in neurological disorders — mechanisms and therapeutic potential
Ravichandran, K. A., & Heneka, M. T. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00915-x · Cited by 117
“Stroke is caused by disruption of the blood supply to the brain as a result of haemorrhage or blockage of a cerebral artery 186 .”
Organ‐On‐A‐Chip Models of the Blood–Brain Barrier: Recent Advances and Future Prospects
Kawakita, S., Mandal, K., Mou, L., Mecwan, M. M., Zhu, Y., Li, S., Sharma, S., Hernández, A. L., Nguyen, H. T., Maity, S., et al. (2022) · Small · doi:10.1002/smll.202201401 · Cited by 112
Molecular Pathogenesis of Ischemic and Hemorrhagic Strokes: Background and Therapeutic Approaches
Maida, C. D., Norrito, R. L., Rizzica, S., Mazzola, M., Scarantino, E. R., & Tuttolomondo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126297 · Cited by 131
“The plaque accumulates fat inside with connective tissue around it [18].”
BackgroundIschemic Stroke: Pathophysiology and Evolving Treatment Approaches
Majumder, D. (2024) · Neuroscience Insights · doi:10.1177/26331055241292600 · Cited by 130
“15,17 Ischemic stroke is more prevalent than haemorrhagic stroke according to a study conducted.”
Neuroinflammation and energy metabolism: a dual perspective on ischemic stroke
Lei, W., Zhuang, H., Huang, W., & Sun, J. F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06440-3 · Cited by 105
“Following acute stroke, secondary neuroinflammation is a critical pathological process that can both exacerbate brain injury leading to cell death and promote brain tissue repair and functional recovery [2, 4, 5].”
InfluentialLi, B., Wang, W., Li, Y., Wang, S., Liu, H., Xia, Z., Gao, W., & Zhao, B. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114269 · Cited by 86
Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin
Thomas, S. D., Jha, N. K., Jha, S. K., Sadek, B. S., & Ojha, S. K. (2023) · Nutrients · doi:10.3390/nu15020385 · Cited by 98
“Inflammation, apoptosis, and oxidative stress are involved in the pathogenesis of ischemic stroke [32].”
BackgroundLemon, N. L., Canepa, E., Ilies, M. A., & Fossati, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772278 · Cited by 93
“When IS occurs, it promptly causes multiple detrimental cerebral injuries due to both the lack of oxygen and glucose, as well as the associated proinflammatory signaling (Faraco et al., 2007; Freitas-Andrade et al., 2020; Kuriakose and Xiao, 2020; Sarvari et al., 2020).”
BackgroundNew Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases
Sun, Y., Yang, Y., Liu, S., Yang, S., Chen, C., Lin, M., Zeng, Q., Long, J., Yao, J., Yi, F., et al. (2022) · Cells · doi:10.3390/cells11162529 · Cited by 86
“The main causes are hypertension, vascular system damage, and excessive use of anticoagulants and thrombolytic agents [52].”
BackgroundLiang, Y., Dai, X., Cao, Y. L., Wang, X., Lu, J., Xie, L., Liu, K., & Li, X. (2022) · Biochimie · doi:10.1016/j.biochi.2022.10.009 · Cited by 89
Guo, X., Liu, R., Jia, M., Wang, Q., & Wu, J. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03923-x · Cited by 87
“However, the pathophysiology of ischemic stroke features an abrupt failure of blood flow supply to a specific brain region, which leads to insufficient oxygen and glucose in the ischemic brain tissue [1].”
BackgroundCelastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke
Hong, Z., Cao, J., Liu, D., Liu, M., Chen, M., Zeng, F., Qin, Z., Wang, J., & Tao, T. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.12.002 · Cited by 80
“Ischemic stroke accounts for approximately 87% of all cases [2].”
BackgroundNeutrophil Extracellular Traps in Cerebral Ischemia/Reperfusion Injury: Friend and Foe
Luo, H., Guo, H., Zhou, Y., Fang, R., Zhang, W., & Mei, Z. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230308090351 · Cited by 82
“Notably, NETs may contribute to the pathogenesis of systemic lupus erythematosus [36], rheumatoid arthritis [37], atherosclerosis [38, 39], systemic vasculitides [40], as well as CNS diseases, including cerebral ischemic stroke [2], AD [41].”
BackgroundLi, J., He, D., Yu, J., Chen, S., Wu, Q., Cheng, Z., Wei, Q., Xu, Y., Zhu, Y., & Wu, S. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s378309 · Cited by 86
“The development of CVD may be attributable to key events such as loss of homeostasis, acidosis, increased intracellular calcium levels, and excitotoxicity.(6,7) Previous studies have suggested that chronic low-grade inflammation is a significant contributing factor in the pathogenesis of CVD.”
BackgroundMicroglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges
Shui, X., Chen, J., Fu, Z., Zhu, H., Tao, H., & Li, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s461795 · Cited by 85
“Bridging proteins, such as growth arrest-specific gene 6 and milk fat globule-EGF factor 8, bind to PS to facilitate indirect recognition.”
BackgroundGupta, R. V., Sahu, M., Tripathi, R. S., Ambasta, R. K., & Kumar, P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101579 · Cited by 72
Yuan, Y., Peng, S., Ma, B., Xue, B., Shen, M., Zhang, L., Li, D., Hou, J., Ren, J., Liu, J., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154934 · Cited by 67
Nanozyme enabled protective therapy for neurological diseases
Cheng, F., Kotha, S., Fu, M., Yang, Q., Wang, H., He, W., & Mao, X. (2024) · Nano Today · doi:10.1016/j.nantod.2023.102142 · Cited by 67
Nose‐to‐Brain Delivery of Circular RNA SCMH1‐Loaded Lipid Nanoparticles for Ischemic Stroke Therapy
Jia, Y., Xu, L., Leng, S., Sun, Y., Huang, X., Wang, Y., Ren, H., Li, G., Bai, Y., Zhang, Z., et al. (2025) · Advanced Materials · doi:10.1002/adma.202500598 · Cited by 73
Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?
Liang, H., Zhang, Q., Hu, Y., Liu, G., & Qi, R. (2022) · Journal of Stroke · doi:10.5853/jos.2021.02831 · Cited by 85
“Stroke is a highly prevalent disease, especially in developing countries.(1,2) According to the Guidelines for the Primary Prevention of Stroke published by the American Heart Association/ American Stroke Association (AHA/ASA), the risk factors for stroke include dyslipidemia, overweight and obesity, metabolic syndrom…”
BackgroundMolecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders
Wu, C., Zou, P., Feng, S., Zhu, L., Li, F., Liu, T. C., Duan, R., & Yang, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03175-w · Cited by 71
Neuroprotection during Thrombectomy for Acute Ischemic Stroke: A Review of Future Therapies
Dammavalam, V. M., Lin, S. Y., Nessa, S., Daksla, N., Stefanowski, K., Costa, A., & Bergese, S. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020891 · Cited by 66
“Furthermore, infarcted tissue experiences acidosis, inflammation, excitotoxicity, free radical-mediated toxicity, cytokine-mediated cytotoxicity, complement activation, oxidative stress, breakdown of the blood–brain barrier, and infiltration of leukocytes [5].”
BackgroundThomas, S., Plumber, N., Venkatapathappa, P., & Gorantla, V. R. (2021) · International Journal of Vascular Medicine · doi:10.1155/2021/4244267 · Cited by 78
“Strokes, in general, can occur for a variety of reasons, including modifiable risk factors like diet, exercise, and environmental conditions, as well as nonmodifiable risk factors like genetic predisposition, age, and gender [5, 6].”
BackgroundShukla, N., Chetri, P., Boruah, R., Gogoi, A., & Ahmed, G. A. (2022) · Lecture notes in nanoscale science and technology · doi:10.1007/978-3-030-99491-4_6 · Cited by 58
“It mainly occurs when a blood vessel that carries oxygen and nutrients to the brain bursts or gets blocked by a clot [162].”
BackgroundHossain, M. M., Ahmed, M. M., Nafi, A. A. N., Islam, M. R., Ali, M. S., Haque, J., Miah, M. S., Rahman, M. M., & Islam, M. K. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109711 · Cited by 72
Kelmanson, I. V., Shokhina, A. G., Kotova, D. A., Pochechuev, M. S., Ivanova, A. D., Kostyuk, A. I., Panova, A. S., Borodinova, A. A., Solotenkov, M. A., Stepanov, E. A., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102178 · Cited by 57
“Hypoxia of the brain can be caused by cardiac arrest, respiratory failure or impaired local blood flow (ischemia), caused by the narrowing or complete obstruction of the blood vessel [2].”
BackgroundNeuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology
Kong, J., Chu, R., & Wang, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202209405 · Cited by 57
Brazilian practice guidelines for stroke rehabilitation: Part II
Minelli, C., Luvizutto, G. J., Cacho, R. D. O., Neves, L. D. O., Magalhães, S. C. S. A., Pedatella, M. T. A., de Mendonça, L. I. Z., Ortiz, K. Z., Lange, M. C., Ribeiro, P. W., et al. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0042-1757692 · Cited by 92
Analyzing stroke burden and risk factors in India using data from the Global Burden of Disease Study
Behera, D. K., Rahut, D. B., & Mishra, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-72551-4 · Cited by 72
Functional Ability and Health Problems of Stroke Survivors: An Explorative Study
Poomalai, G., Prabhakar, S., & Jagadesh, N. S. (2023) · Cureus · doi:10.7759/cureus.33375 · Cited by 88
“The needs of these patients can be complex according to the temporal phase of their illness, the cause and severity of their stroke, and other factors, including the presence of other chronic health conditions [3].”
BackgroundMesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?
Isaković, J., Šerer, K., Barišić, B., & Mitrečić, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1139359 · Cited by 65
“Since ischemic stroke includes many pathophysiological events which occur in parallel, from ion imbalance and hyperinflammation to activation of various types of cell death, transplantation of stem cells might bring a multitude of benefits (Kuriakose and Xiao, 2020).”
BackgroundThe Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery
Qiao, C., Liu, Z., & Qie, S. (2023) · Biomolecules · doi:10.3390/biom13030571 · Cited by 59
“During this process, stress in the brain and internal injury cause the rupture of blood vessel [13].”
BackgroundZuraini, N. Z. A., Sekar, M., Wu, Y. S., Gan, S. H., Bonam, S. R., Rani, N. N. I. M., Begum, M. Y., Lum, P. T., Subramaniyan, V., Fuloria, N. K., et al. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s328096 · Cited by 63
Deep learning models for ischemic stroke lesion segmentation in medical images: A survey
Luo, J., Dai, P., He, Z., Huang, Z., Liao, S., & Liu, K. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108509 · Cited by 66
Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke
Berlet, R., Anthony, S., Brooks, B., Wang, Z.-J., Sadanandan, N., Shear, A., Cozene, B., Gonzales‐Portillo, B., Parsons, B., Salazar, F. E., et al. (2021) · Biomolecules · doi:10.3390/biom11091316 · Cited by 53
“The economic and social costs of neurological diseases, such as stroke, cause significant distress for patients, families, and society as a whole [3].”
BackgroundNon-invasive Vagus Nerve Stimulation in Cerebral Stroke: Current Status and Future Perspectives
Li, L., Wang, D., Pan, H., Huang, L., Sun, X., He, C., & Wei, Q. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.820665 · Cited by 57
“Despite extensive therapeutic advances in recent years, stroke including ischemic and hemorrhagic (roughly 87 and 13%) (Kuriakose and Xiao, 2020), is still a leading cause of disability and a significant health problem worldwide.”
BackgroundAnti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging
Martínez‐Coria, H., Arrieta‐Cruz, I., Juárez, R. G., & López-Valdés, H. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054297 · Cited by 53
Quantification of dynamic cerebral autoregulation: welcome to the jungle!
Brassard, P., Roy, M., Burma, J. S., Labrecque, L., & Smirl, J. D. (2023) · Clinical Autonomic Research · doi:10.1007/s10286-023-00986-2 · Cited by 59
di Biase, L., Bonura, A., Pecoraro, P. M., Carbone, S. P., & Lazzaro, V. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411545 · Cited by 57
“Stroke is a heterogeneous pathology characterized by different pathophysiological processes that vary from case to case and that may influence the diagnostic performance of a biological marker [21,22].”
BackgroundNatural products in drug discovery and development: Synthesis and medicinal perspective of leonurine
Li, Z., Chen, K., Rose, P., & Zhu, Y. Z. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1036329 · Cited by 47
Garrido, M. A., Evelyn Álvarez, E., Pérez, F. A., Moyano, Á., Castillo-Núñez, N. P., & Cavada, G. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.12.008 · Cited by 67
Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles
Song, J., Zhou, D., Cui, L., Wu, C., Jia, L., Wang, M., Li, J., Ya, J., Ji, X., & Meng, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01752-1 · Cited by 51
“Cerebral vessel occlusion leads to oxygen and glucose deprivation (OGD) in focal brain tissues, precipitating metabolic distress in neurons and glial cells [16, 17].”
BackgroundShou, J., & Shaw, P. (2022) · Cells · doi:10.3390/cells11050796 · Cited by 50
“The current prevention or treatment of stroke includes primary prevention, recanalization and thrombolysis, neuroprotection, secondary prevention, and neurorepair [58,59].”
BackgroundAnimal Models of Ischemic Stroke with Different Forms of Middle Cerebral Artery Occlusion
Zeng, L., Hu, S.-Q., Zeng, L., Chen, R., Li, H., Yu, J., & Yang, H. (2023) · Brain Sciences · doi:10.3390/brainsci13071007 · Cited by 52
Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
Zhu, S., Liu, F., Zhang, R., Xiong, Z., Zhang, Q., Hao, L., & Chen, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857449 · Cited by 48
Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke
Almeida, Á., Sánchez‐Morán, I., & Rodríguez, C. (2021) · IUBMB Life · doi:10.1002/iub.2453 · Cited by 45
Wang, Y., Wu, H., Han, Z., Sheng, H., Wu, Y., Wang, Y., Guo, X., Zhu, Y., Li, X., & Wáng, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154034 · Cited by 46
Zhang, Y., Fu, K., Wang, C., Ma, C., Gong, L., Zhou, H., Xue, X., Peng, C., & Li, Y. (2023) · Food & Function · doi:10.1039/d2fo03122a · Cited by 45
de la Riva, P., Marta-Enguita, J., Rodríguez-Antigüedad, J., Bergareche, A., & de Munaín, A. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111631 · Cited by 51
“Its clinical presentation and progression depend on various pathophysiological factors that converge at the time of the stroke, some of which are related to blood components and their interaction with vessel walls [2].”
BackgroundMyelin dysfunction in aging and brain disorders: mechanisms and therapeutic opportunities
Huang, Z., Zhang, Y., Zou, P., Zong, X., & Zhang, Q. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00861-w · Cited by 53
“Stroke, a life-threatening condition, occurs when blood flow to the brain is disrupted—most commonly due to the blockage of a blood vessel caused by a clot or atherosclerosis, or less frequently, by a hemorrhage resulting from damage to blood vessels [177, 178].”
A review on EMG/EEG based control scheme of upper limb rehabilitation robots for stroke patients
Sarhan, S. M., Al-Faiz, M. Z., & Takhakh, A. M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18308 · Cited by 41
“When the oxygenated blood supply to the brain is cut off, a potentially fatal condition known as a stroke results, and the linked brain cells begin to die after a short period of time [1].”
Kalra, P., Khan, H., Kaur, A., & Singh, T. G. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03500-0 · Cited by 43
Molecular mechanisms of cognitive impairment associated with stroke
Kaur, M., & Sharma, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00901-0 · Cited by 45
“Risk factors for cognitive impairment and dementia associated with stroke are multifactorial including older age (above 65 years), family history, hypertension, arterial fibrillation, diabetes, genetic variants, low educational status, vascular comorbidities, prior transient ischaemic attack or recurrent stroke, depre…”
BackgroundBiomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases
Cassano, R., Servidio, C., & Trombino, S. (2021) · Materials · doi:10.3390/ma14071802 · Cited by 40
“At present, therapeutic approaches are limited and involve mainly reperfusion treatments such as intravenous thrombolysis [107].”
BackgroundBerlet, R., Cabantan, D. A. G., Gonzales-Portillo, D., & Borlongan, C. V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.798826 · Cited by 43
“Approximately 87% of strokes are ischemic, where thrombotic or embolic events disrupt blood supply and deprive neurons of oxygen, leading to acute neuronal injury and death (Kuriakose and Xiao, 2020).”
BackgroundKhan, H., Grewal, A. K., Kumar, M., & Singh, T. G. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.016 · Cited by 41
Taei, A. A., Dargahi, L., Khodabakhsh, P., Kadivar, M., & Farahmandfar, M. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13886 · Cited by 44
Du, L., He, X., Xiong, X., Zhang, X., Jian, Z., & Yang, Z. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389365 · Cited by 44
“…thrombectomy (Xiong et al., 2019; Hasan et al., 2021); however, < 10% patients are effectively managed owing to technical or time limitations (Kuriakose and Xiao, 2020), with approximately 60% patients achieving only some degree of recovery after 6 months (Lee et al., 2015) and residual…”
BackgroundA Comprehensive Review: Robot-Assisted Treatments for Gait Rehabilitation in Stroke Patients
Park, Y., Lee, D.-H., & Lee, J.-H. (2024) · Medicina · doi:10.3390/medicina60040620 · Cited by 47
“This disruption manifests as various gait abnormalities, such as reduced walking speed, asymmetrical gait patterns, and decreased balance [2].”
BackgroundAdvanced Biomaterials in Neuroprotection: Innovations and Clinical Applications
Ramakrishna, K., Viswanadh, M. K., Dumala, N., Chakravarth, G., Venkateswarlu, K., Gutti, G., Yadagiri, G., Duguluri, S., & Nand, S. (2025) · Springer eBooks · doi:10.1007/978-981-97-9959-6_4 · Cited by 49
The Role of Oxidative Stress in Ischaemic Stroke and the Influence of Gut Microbiota
Golenia, A., & Olejnik, P. (2025) · Antioxidants · doi:10.3390/antiox14050542 · Cited by 45
3D U-Net for brain stroke lesion segmentation on ISLES 2018 dataset
Tursynova, A., & Omarov, B. S. (2021) · International Conference on Electronics, Computer and Computation · doi:10.1109/icecco53203.2021.9663825 · Cited by 37
Zhang, B., Wong, K. P., Kang, R., Fu, S., Qin, J., & Xiao, Q. (2023) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2023.04.005 · Cited by 46
Mohan, M., Mannan, A., Kakkar, C., & Singh, T. G. (2024) · Current Drug Targets · doi:10.2174/0113894501320839240918110656 · Cited by 41
Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
Poznyak, A. V., Kashirskikh, D. A., Sukhorukov, V. N., Kalmykov, V. A., Omelchenko, A. V., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031332 · Cited by 38
“In the Dallas Heart study (a younger population with fewer events took part), the ability to outflow was inversely related to stroke in secondary analyses [67].”
BackgroundSubudhi, A. K., Dash, P., Mohapatra, M., Tan, R., Acharya, U. R., & Sabut, S. (2022) · Diagnostics · doi:10.3390/diagnostics12102535 · Cited by 42
“Approximately 70% of all stroke cases are ischemic in nature and the condition is observed with neurological deficit which persists beyond 24 h or is interrupted by death within 24 h [8].”
BackgroundYüksel, M., Sun, S., Latchoumane, C.-F. V., Bloch, J., Courtine, G., Raffin, E., & Hummel, F. C. (2023) · IEEE Open Journal of Engineering in Medicine and Biology · doi:10.1109/ojemb.2023.3263690 · Cited by 41
Zhang, Y., Zhang, Z., Wang, J., Zhang, X., Zhao, J., Bai, N., Vijayalakshmi, A., & Huo, Q. (2022) · Environmental Toxicology · doi:10.1002/tox.23645 · Cited by 39
“Others are hemorrhagic (subarachnoid hemorrhage, ischemic stroke, and intracerebral hemorrhage).(5)”
BackgroundZhao, Y., Han, P.-P., Zhang, X., & Bi, X. (2024) · Medical Science Monitor · doi:10.12659/msm.943785 · Cited by 50
“Stroke is a common neurological disease characterized by vascular blockage, with high morbidity, disability, and mortality rates, and is currently the second leading cause of death and disability worldwide [1,2].”
BackgroundHDAC1 is Involved in Neuroinflammation and Blood-Brain Barrier Damage in Stroke Pathogenesis
Wang, H., Su, Y.-T., Ho, Y., Lee, Y., Chu, T., Chen, K.-T., & Wu, C. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s416239 · Cited by 35
“from the interruption of adequate blood and oxygen supply to the brain, leading to neuronal death and brain functional impairment.(1,2) Approximately 14 million individuals have stroke per year; among them, 5.”
BackgroundImprovements in functionality and quality of life after aquatic therapy in stroke survivors
Auza-Santiváñez, J. C., Lopez-Quispe, A. G., Carías, A., Apaza-Huanca, B., Remón, A. S., Condo-Gutierrez, A. R., Manzaneda, L. P. M., Gómez, L. M. T., Santander, I. O., Condori-Villca, N., et al. (2023) · Salud Integral y Comunitaria · doi:10.62486/agsalud202315 · Cited by 74
The most efficient machine learning algorithms in stroke prediction: A systematic review
Asadi, F., Rahimi, M., Daeechini, A. H., & Paghe, A. (2024) · Health Science Reports · doi:10.1002/hsr2.70062 · Cited by 42
Zhang, H., Wang, X., Chen, W., Yang, Y., Wang, Y., Wan, H., & Zhu, Z. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115724 · Cited by 36
Zeng, J., Yang, K., Nie, H., Le, Y., Wang, S., Zeng, L., Ge, A., & Ge, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114026 · Cited by 37
Shi, X., Zhang, L., Wu, S., Zhang, C., Mamtilahun, M., Li, Y.-F., Zhang, Z., Zuo, C., Cui, F., Li, W., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70031 · Cited by 34
“…smart ROS scavengers in oxidative stress (Xu et al., 2023); thus, the PDA layer could serve as a protective shell on EVs, helping them withstand oxidative stress, inflammation and mechanical injury common in ischemic stroke (Kuriakose & Xiao, 2020), thereby maintaining their structural stability.”
Vabalaitė, B., Petrusevičienė, L., Savickas, R., Kubilius, R., Ignatavičius, P., & Lendraitienė, E. (2021) · Medicina · doi:10.3390/medicina57111215 · Cited by 37
“Despite the growing knowledge about etiology and risk factors, stroke remains the leading cause of serious long-term adult disability worldwide [1,2].”
BackgroundLin, Y., Liu, S., Sun, Y., Chen, C., Yang, S., Pei, G., Lin, M., Yu, J., Liu, X., Wang, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102286 · Cited by 33
Neuroprotective Effects of Guanosine in Ischemic Stroke—Small Steps towards Effective Therapy
Chojnowski, K., Opiełka, M., Nazar, W., Kowiański, P., & Smolenski, R. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136898 · Cited by 33
“Ischemic stroke is characterized by a transient or permanent reduction of cerebral blood flow, causing the depletion of oxygen and glucose levels, uncontrolled depolarization, energy deficit, excitotoxicity, and tissue infarct, thus disturbing physiological cellular function [5].”
BackgroundChiang, M., Nicol, C. J. B., Lo, S.-S., Hung, S.-W., Wang, C.-J., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911678 · Cited by 40
“ischemic stroke is primarily a temporary or permanent blockage or blood clot in an artery in the brain, further reducing blood flow to a specific brain area [5].”
BackgroundFerroptosis: A new strategy for traditional Chinese medicine treatment of stroke
Lou, Y., Ma, M., Jiang, Y., Xu, H., Gao, Z., Gao, L., & Wang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113806 · Cited by 33
Choi, S. G., Shin, J., Lee, K. Y., Park, H., Kim, S. I., Yi, Y. Y., Kim, D. W., Song, H., & Shin, H. J. (2023) · Glia · doi:10.1002/glia.24339 · Cited by 33
“On the other hand, the RB-induced PTS model is highly reproducible, non-invasive, causes low mortality, and can be generated locally in the mouse brain (Kuriakose & Xiao, 2020; Labat-gest & Tomasi, 2013).”
Background
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


